Published in Transcription on May 01, 2011
TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature (2015) 2.33
RNA polymerase II acts as an RNA-dependent RNA polymerase to extend and destabilize a non-coding RNA. EMBO J (2013) 1.68
Hierarchical molecular events driven by oocyte-specific factors lead to rapid and extensive reprogramming. Mol Cell (2014) 1.52
Single mammalian cells compensate for differences in cellular volume and DNA copy number through independent global transcriptional mechanisms. Mol Cell (2015) 1.48
Lin28A Binds Active Promoters and Recruits Tet1 to Regulate Gene Expression. Mol Cell (2015) 1.44
MYC regulates the non-coding transcriptome. Oncotarget (2014) 1.29
CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo. Nucleic Acids Res (2012) 1.05
Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1. Cell Death Differ (2013) 1.04
Hira-mediated H3.3 incorporation is required for DNA replication and ribosomal RNA transcription in the mouse zygote. Dev Cell (2014) 1.04
A long non-coding RNA is required for targeting centromeric protein A to the human centromere. Elife (2014) 1.03
The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1. PLoS Genet (2013) 1.02
Transcriptome-wide modulation of splicing by the exon junction complex. Genome Biol (2014) 0.94
Mediator promotes CENP-a incorporation at fission yeast centromeres. Mol Cell Biol (2012) 0.89
The Maternal-to-Zygotic Transition During Vertebrate Development: A Model for Reprogramming. Curr Top Dev Biol (2015) 0.89
Downregulation of rRNA transcription triggers cell differentiation. PLoS One (2014) 0.89
RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1. Oncogene (2013) 0.88
The trithorax group proteins Kismet and ASH1 promote H3K36 dimethylation to counteract Polycomb group repression in Drosophila. Development (2013) 0.87
The cell's nucleolus: an emerging target for chemotherapeutic intervention. ChemMedChem (2013) 0.86
Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. Mol Biol Cell (2014) 0.85
Quantifying the dynamics of the oligomeric transcription factor STAT3 by pair correlation of molecular brightness. Nat Commun (2016) 0.85
Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation. PLoS One (2013) 0.85
Global SUMOylation on active chromatin is an acute heat stress response restricting transcription. Genome Biol (2015) 0.84
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Oncotarget (2014) 0.84
Canonical Poly(A) Polymerase Activity Promotes the Decay of a Wide Variety of Mammalian Nuclear RNAs. PLoS Genet (2015) 0.84
ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. J Biol Chem (2016) 0.82
Nucleolar integrity is required for the maintenance of long-term synaptic plasticity. PLoS One (2014) 0.82
Temperature regulates splicing efficiency of the cold-inducible RNA-binding protein gene Cirbp. Genes Dev (2016) 0.82
Centromeric Transcription Regulates Aurora-B Localization and Activation. Cell Rep (2016) 0.82
Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD. Nucleic Acids Res (2015) 0.81
Identification of novel markers that demarcate the nucleolus during severe stress and chemotherapeutic treatment. PLoS One (2013) 0.80
Direct binding of the Alu binding protein dimer SRP9/14 to 40S ribosomal subunits promotes stress granule formation and is regulated by Alu RNA. Nucleic Acids Res (2014) 0.80
Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. Mol Ther (2013) 0.80
Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression. J Biol Chem (2015) 0.79
Distinct allelic patterns of nanog expression impart embryonic stem cell population heterogeneity. PLoS Comput Biol (2013) 0.79
RNA Polymerase II cluster dynamics predict mRNA output in living cells. Elife (2016) 0.79
Myosin-Va-dependent cell-to-cell transfer of RNA from Schwann cells to axons. PLoS One (2013) 0.79
Quantification of nascent transcription by bromouridine immunocapture nuclear run-on RT-qPCR. Nat Protoc (2015) 0.79
Click-EM for imaging metabolically tagged nonprotein biomolecules. Nat Chem Biol (2016) 0.78
A Function for the hnRNP A1/A2 Proteins in Transcription Elongation. PLoS One (2015) 0.78
A versatile toolbox for posttranscriptional chemical labeling and imaging of RNA. Nucleic Acids Res (2015) 0.78
Monoaminergic tone supports conductance correlations and stabilizes activity features in pattern generating neurons of the lobster, Panulirus interruptus. Front Neural Circuits (2015) 0.78
Single Cell Assay for Molecular Diagnostics and Medicine: Monitoring Intracellular Concentrations of Macromolecules by Two-photon Fluorescence Lifetime Imaging. Theranostics (2015) 0.77
GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells. Protein Expr Purif (2013) 0.77
Influence of untranslated regions on retroviral mRNA transfer and expression. BMC Biotechnol (2013) 0.77
Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models. Cell Rep (2015) 0.77
An in vitro enzymatic assay to measure transcription inhibition by gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles. J Vis Exp (2015) 0.77
Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway. Mol Biol Cell (2013) 0.77
HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells. J Virol (2014) 0.76
A cleavage clock regulates features of lineage-specific differentiation in the development of a basal branching metazoan, the ctenophore Mnemiopsis leidyi. Evodevo (2014) 0.76
Suggested Involvement of PP1/PP2A Activity and De Novo Gene Expression in Anhydrobiotic Survival in a Tardigrade, Hypsibius dujardini, by Chemical Genetic Approach. PLoS One (2015) 0.76
Transcriptome-wide effects of inverted SINEs on gene expression and their impact on RNA polymerase II activity. Genome Biol (2016) 0.76
Functional interplay between PPM1G and the transcription elongation machinery. RNA Dis (2016) 0.76
Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein. BMC Cancer (2015) 0.76
Bromodomain factors of BET family are new essential actors of pericentric heterochromatin transcriptional activation in response to heat shock. Sci Rep (2017) 0.75
Promoter occupancy of STAT1 in interferon responses is regulated by processive transcription. Mol Cell Biol (2014) 0.75
Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue. Sci Rep (2017) 0.75
Stress induces changes in the phosphorylation of Trypanosoma cruzi RNA polymerase II, affecting its association with chromatin and RNA processing. Eukaryot Cell (2014) 0.75
Insights into centromeric transcription in mitosis. Transcription (2016) 0.75
An Ounce of Tat Prevention Is Worth a Pound of Functional Cure. MBio (2015) 0.75
α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15. Sci Rep (2016) 0.75
SIRT1 is a critical regulator of K562 cell growth, survival, and differentiation. Exp Cell Res (2016) 0.75
Transcription regulation during stable elongation by a reversible halt of RNA polymerase II. Mol Biol Cell (2014) 0.75
Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proc Natl Acad Sci U S A (2016) 0.75
Repression of breast cancer cell growth by proteasome inhibitors in vitro: impact of mitogen-activated protein kinase phosphatase 1. Cancer Biol Ther (2015) 0.75
P-TEFb Kinase Activity Is Essential for Global Transcription, Resumption of Meiosis and Embryonic Genome Activation in Pig. PLoS One (2016) 0.75
Osmolality/salinity-responsive enhancers (OSREs) control induction of osmoprotective genes in euryhaline fish. Proc Natl Acad Sci U S A (2017) 0.75
Increases in Retrograde Injury Signaling Complex-Related Transcripts in Central Axons following Injury. Neural Plast (2016) 0.75
Protein Phosphatase-1 regulates Rift Valley fever virus replication. Antiviral Res (2016) 0.75
Super-resolution imaging of fluorescently labeled, endogenous RNA Polymerase II in living cells with CRISPR/Cas9-mediated gene editing. Sci Rep (2016) 0.75
Fluid consumption and taste novelty determines transcription temporal dynamics in the gustatory cortex. Mol Brain (2016) 0.75
Total RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis. Nat Chem Biol (2017) 0.75
Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation. Genes Dev (2016) 0.75
DNA damage-induced ATR kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor II-H (TFIIH). J Biol Chem (2017) 0.75
MRTF transcription and Ezrin-dependent plasma membrane blebbing are required for entotic invasion. J Cell Biol (2017) 0.75
Piwi interacts with chromatin at nuclear pores and promiscuously binds nuclear transcripts in Drosophila ovarian somatic cells. Nucleic Acids Res (2017) 0.75
Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. PLoS One (2017) 0.75
Transcriptional Output Transiently Spikes Upon Mitotic Exit. Sci Rep (2017) 0.75
Amplification of unscheduled DNA synthesis signal enables fluorescence-based single cell quantification of transcription-coupled nucleotide excision repair. Nucleic Acids Res (2017) 0.75
Induction of Proteotoxic Stress by the Mycotoxin Patulin. Toxicol Lett (2017) 0.75
Real-Time Imaging of a Single Gene Reveals Transcription-Initiated Local Confinement. Biophys J (2017) 0.75
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Visualization of single RNA transcripts in situ. Science (1998) 10.51
Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol (2002) 8.81
Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature (1992) 8.45
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev (1997) 6.88
Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem (1996) 6.78
Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem (2001) 5.36
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev (1997) 5.13
7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature (2001) 5.11
Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 snRNPs in coiled bodies. J Cell Biol (1992) 4.57
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell (2005) 4.16
Features of selective kinase inhibitors. Chem Biol (2005) 4.07
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev (2006) 4.06
Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J Cell Physiol (1970) 3.98
Selective inhibition of the synthesis of mitochondria-associated RNA by ethidium bromide. J Mol Biol (1969) 3.91
The nucleolus under stress. Mol Cell (2010) 3.63
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol Mol Biol Rev (2006) 3.44
Rates of in situ transcription and splicing in large human genes. Nat Struct Mol Biol (2009) 3.39
Fluorescence in situ hybridization: past, present and future. J Cell Sci (2003) 3.20
Transcriptional regulation by p53. Cold Spring Harb Perspect Biol (2010) 3.16
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem (2000) 3.13
Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci U S A (1974) 2.95
Close association of RNA polymerase II and many transcription factors with Pol III genes. Proc Natl Acad Sci U S A (2010) 2.90
Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. Biochim Biophys Acta (2010) 2.86
Magic bullets for protein kinases. Trends Cell Biol (2001) 2.65
The RNA polymerase II trigger loop functions in substrate selection and is directly targeted by alpha-amanitin. Mol Cell (2008) 2.62
In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res (1996) 2.53
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Structural basis of transcription inhibition by alpha-amanitin and implications for RNA polymerase II translocation. Nat Struct Mol Biol (2008) 2.47
Structural basis of transcription: alpha-amanitin-RNA polymerase II cocrystal at 2.8 A resolution. Proc Natl Acad Sci U S A (2002) 2.37
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J (2008) 2.36
Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition. Mol Biol Cell (2005) 2.36
Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J Biol Chem (2010) 2.00
DRB-induced premature termination of late adenovirus transcription. Nature (1978) 1.98
XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat Chem Biol (2011) 1.89
Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res (2010) 1.80
Transcriptional signature of flavopiridol-induced tumor cell death. Mol Cancer Ther (2004) 1.80
RNA-based affinity purification reveals 7SK RNPs with distinct composition and regulation. RNA (2007) 1.77
5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells. Science (1976) 1.77
Chemical-genomic dissection of the CTD code. Nat Struct Mol Biol (2010) 1.76
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A (2007) 1.75
Inducible gene expression systems for higher eukaryotic cells. Curr Opin Biotechnol (1994) 1.69
CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing. EMBO Rep (2009) 1.69
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents. Chem Biol (2010) 1.66
P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes. EMBO J (2005) 1.66
5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev (2010) 1.64
Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy. Cell Cycle (2009) 1.64
Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol (2011) 1.53
Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb. EMBO J (2007) 1.52
Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Retrovirology (2007) 1.48
Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. Proc Natl Acad Sci U S A (1988) 1.44
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia. Blood (2009) 1.42
Structural evidence for two alpha-amanitin sensitive RNA polymerases in calf thymus. FEBS Lett (1971) 1.42
Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci (2006) 1.40
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry (1990) 1.37
Extragenic accumulation of RNA polymerase II enhances transcription by RNA polymerase III. PLoS Genet (2007) 1.34
The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes. Mol Cell Biol (2007) 1.32
Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA. Mol Cancer Ther (2009) 1.32
Defects in 18 S or 28 S rRNA processing activate the p53 pathway. J Biol Chem (2010) 1.30
Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol (2010) 1.30
The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase II C-terminal domain. J Biol Chem (1999) 1.29
Non-coding RNAs regulating the transcriptional machinery. Biol Cell (2008) 1.29
Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res (1994) 1.26
Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res (2010) 1.21
RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase. J Biol Chem (2005) 1.19
Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Cancer Res (2004) 1.18
Induction of murine erythroleukemia differentiation by actinomycin D. Proc Natl Acad Sci U S A (1978) 1.15
The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J Mol Biol (2001) 1.14
The transcription stress response. Cell Cycle (2007) 1.13
Halogen bonds form the basis for selective P-TEFb inhibition by DRB. Chem Biol (2010) 1.08
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples. Cancer Chemother Pharmacol (2009) 1.08
Clustered alpha-amanitin resistance mutations in mouse. Mol Gen Genet (1995) 1.07
Actinomycin D induces histone gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA helicase II. J Biol Chem (2004) 1.06
Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure. Cancer Res (2008) 1.06
Drosophila RNA polymerase II mutants that affect transcription elongation. J Biol Chem (1996) 1.05
Transcription inhibition by platinum-DNA cross-links in live mammalian cells. J Am Chem Soc (2010) 1.05
Actinomycin D; renewed RNA synthesis after removal from mammalian cells. Science (1971) 1.05
Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9. Arterioscler Thromb Vasc Biol (2010) 1.03
Actinomycin D stimulates the transcription of rRNA minigenes transfected into mouse cells. Implications for the in vivo hypersensitivity of rRNA gene transcription. Eur J Biochem (1995) 0.98
Phosphorylation of the RNA polymerase II largest subunit during heat shock and inhibition of transcription in HeLa cells. J Cell Physiol (1994) 0.98
Mitochondrial liaisons of p53. Antioxid Redox Signal (2011) 0.97
Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol Pharmacol (2008) 0.96
Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy. Mini Rev Med Chem (2010) 0.94
The perinucleolar compartment. J Cell Biochem (2009) 0.92
Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin. Clin Cancer Res (2008) 0.91
Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation. Exp Cell Res (1998) 0.90
RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes. J Cell Physiol (1996) 0.89
Novel agents for the treatment of chronic lymphocytic leukemia. Clin Adv Hematol Oncol (2010) 0.88
Transcription-dependent polyubiquitination of RNA polymerase II requires lysine 63 of ubiquitin. Biochemistry (2004) 0.88
Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target. Biochemistry (2000) 0.86
Histone H1b phosphorylation is dependent upon ongoing transcription and replication in normal and ras-transformed mouse fibroblasts. J Biol Chem (1997) 0.86
P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents. Oncogene (2007) 0.83
A transcription inhibitor, actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway. J Acquir Immune Defic Syndr (2005) 0.81
A mutation in the largest (catalytic) subunit of RNA polymerase II and its relation to the arrest of the cell cycle in G(1) phase. Gene (2001) 0.79
Study on genes with altered expression in alpha-amanitin poisoned mice and evaluation on antagonistic effects of traditional Chinese medicines against toxicity of alpha-amanitin. Acta Biol Hung (2009) 0.76